Results 1 to 10 of about 11,654 (178)

Cytotoxic T-cell deficiency and sustained B-cell activation in serofast syphilis: a prospective observational study [PDF]

Frontiers in Immunology
IntroductionThe serofast state, defined by persistent non-treponemal reactivity after adequate therapy for syphilis, remains a clinically relevant yet poorly understood condition.
Konrad Kaminiów, Martyna Kiołbasa, Katarzyna Napiórkowska-Baran, Katarzyna Napiórkowska-Baran, Maciej Pastuszczak   +4 more
doaj   +2 more sources

Anticardiolipin antibodies in pathogenesis of infertility [PDF]

Vojnosanitetski Pregled, 2010
Background/Aim. Antiphospholipid syndrome (APS) is an autoimmune disorder clinically characterized by arterial or venous thrombosis and/or specific obstetric complications and presence of antiphospholipid antibodies (aPL) in the serum.
Lončar Dragan
doaj   +3 more sources

Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes

Frontiers in Immunology, 2022
ObjectiveThe purpose of the study is to evaluate the effects of anticardiolipin (aCL) and/or anti-β2-glycoprotein-I (aβ2GPI) antibodies, namely antiphospholipid antibodies (aPL), on in vitro fertilization (IVF) outcomes.Materials and methodsThe study ...
Li Wu, Xuhui Fang, Fangting Lu, Yu Zhang, Yanshi Wang, Joanne Kwak-Kim, Joanne Kwak-Kim   +6 more
doaj   +1 more source

Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks

International Journal of Preventive Medicine, 2023
Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19.
Somayeh Haghighipour, Mansour Salesi, Fereshteh Keikhaei, Mohammad J. Tarrahi, Zahra Khani, Hassan Salehi   +5 more
doaj   +1 more source

Evaluation of Serum Anticardiolipin Antibodies and D-dimer in Recipients of COVID-19 Vaccines in Ado-Ekiti, Ekiti State, Nigeria

Journal of Applied Sciences and Environmental Management, 2023
Coronavirus disease 2019 (COVID-19) manifests itself in a variety of ways, implying a wide range of host autoimmune responses which could lead to disseminated intravascular coagulation.
O. O. Odewusi, J. J. Dodo, F. E. Omotayo, S. O. Obadire, E. A. Omon, M. O. Oguntuase, O. A. Alake   +6 more
doaj   +1 more source

Prevalence of anticardiolipin antibody IgM and IgG in women with recurrent abortions in Kirkuk city

NTU Journal of Pure Sciences, 2023
Toxoplasma gondii, a parasite that can produce a wide range of clinical symptoms in humans, is the source of the zoonotic infection known as Toxoplasmosis.
Muna Aziz, Abeer Ali, Mohammed Hameed
doaj   +1 more source

Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers

Biomedicines, 2021
Antiphospholipid antibodies (aPL) are a cluster of autoantibodies directed against plasma proteins with affinity for membrane phospholipids. The most frequently tested aPL are lupus anticoagulant (LA), anti-cardiolipin antibodies (aCL), and anti-β2 ...
Ilenia Calcaterra, Pasquale Ambrosino, Nicoletta Vitelli, Roberta Lupoli, Roberta Clara Orsini, Martina Chiurazzi, Mauro Maniscalco, Matteo Nicola Dario Di Minno   +7 more
doaj   +1 more source

Study on Anticardiolipin Antibodies in Women With Recurrent Abortion in Duhok Province, Kurdistan Region, Iraq

Acta Medica Iranica, 2020
Recurrent abortion is a worldwide issue. Anticardiolipin antibodies (ACA) are found to be among the most important factors related to recurrent spontaneous early pregnancy loss.
Ibrahim A Naqid, Shivan H. Yousif, Amer A Balatay, Djwar Ali Khasho, Nawfal R. Hussein   +4 more
doaj   +1 more source

Anticardiolipin antibodies and severe leptospirosis [PDF]

Revista do Instituto de Medicina Tropical de São Paulo, 2003
Laurent RODA
doaj   +5 more sources

Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?

Biomedicines, 2021
The antiphospholipid syndrome (APS) is characterized by the development of venous and/or arterial thrombosis and pregnancy morbidity in patients with persistent antiphospholipid antibodies (aPL).
Ilaria Mormile, Francescopaolo Granata, Alessandra Punziano, Amato de Paulis, Francesca Wanda Rossi   +4 more
doaj   +1 more source